Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. (Q35586987)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 March 2015

Language	Label	Description	Also known as
English	Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.	scientific article published on 25 March 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

phase II clinical trial

0 references

0 references

multicenter clinical trial

0 references

0 references

0 references

Poong-Lyul Rhee

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

C H Choi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

J G Kwon

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

S K Kim

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

S-J Myung

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

K S Park

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

C-I Sohn

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

K J Lee

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

O Y Lee

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

H-K Jung

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

S R Jee

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Y T Jeen

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

M-G Choi

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

S C Choi

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

K C Huh

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

H Park

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 March 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Neurogastroenterology and Motility

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

705-716

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

The immune system in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Peripheral mechanisms in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Guidelines on the irritable bowel syndrome: mechanisms and practical management.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Irritable bowel syndrome, gut microbiota and probiotics.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Intestinal microbiota in functional bowel disorders: a Rome foundation report

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Rifaximin therapy for patients with irritable bowel syndrome without constipation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

The mechanism of action of probiotics

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Consumption of fermented milk product with probiotic modulates brain activity

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

The serotonin signaling system: from basic understanding to drug development for functional GI disorders

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Mosapride in gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

The effect of mosapride citrate on constipation in patients with diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Design of treatment trials for functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Cross-cultural validation of Irritable Bowel Syndrome Quality of Life in Korea

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12544

21 January 2018

Identifiers

10.1111/NMO.12544

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

release_skzmbnv3svfbrjhkiumtnkovay

1 reference

https://api.fatcat.wiki/v0/release/skzmbnv3svfbrjhkiumtnkovay

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25809913%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35586987&oldid=1838927044"